GMP compliance starts with data integrity. Discover a practical checklist of common risks in regulated labs and learn how to spot red flags before they become inspection findings.

Cell & Gene Therapy equipment for GMP-ready scale-up: discover key features like closed processing, data integrity, and validation support to reduce risk and speed commercialization.

EMA launches data integrity spot checks on Q-TOF systems in the EU. Learn how CSV, audit trails, data retention, and user access controls may affect CE mark status, GMP declarations, and supplier access.

FDA draft guidance signals faster CGT reviews by enabling platform knowledge reuse in CMC, nonclinical, and clinical filings. See how gene editing suppliers can adapt export and GMP strategies.